accessibility menu, dialog, popup

UserName
Viewing profile as user:

Phenylacetic acids

Organic compounds that consist of a phenyl group with a carboxylic acid group substitution; a carboxylic acid contains a carbon atom bonded to both a carbonyl group and a hydroxyl group.

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (3)
  • (1)

special interests

  • (4)

Search Within Results
Keyword Search:
1 – 4 of 4 results
1

Medchemexpress LLC Diclofenac diethylamine | 78213-16-8 | 500 MG
SDP

Diclofenac diethylamine is a potent and nonselective anti-inflammatory agent that acts as a COX inhibitor. It demonstrates IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells, and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively. This compound also induces apoptosis of neural stem cells (NSCs) by activating the caspase cascade.

  • Potent and nonselective anti-inflammatory activity.
  • Effective COX inhibitor in both human and ovine cells.
  • Induces apoptosis in neural stem cells through caspase cascade activation.

ENCOMPASS_PREFERRED
2

Medchemexpress LLC Diclofenac | 15307-86-5 | C14H11Cl2NO2 | 500 MG
SDP

Diclofenac is a potent and nonselective anti-inflammatory agent that acts as a COX inhibitor. It induces apoptosis of neural stem cells (NSCs) by activating the caspase cascade.

  • Potent and nonselective anti-inflammatory properties
  • Inhibits COX enzymes
  • Induces apoptosis in neural stem cells
  • Activates caspase cascade

ENCOMPASS_PREFERRED
3

Selleck Chemical LLC Evocalcet-E0359-5MG
SDP

Evocalcet (KHK7580) is an novel oral calcimimetic agent which acts via allosteric activation of the calcium sensing receptor (CaSR) Evocalcet (0 20 and 60 nM) dose-dependently increases cytoplasmic [Ca2 ] concentrations with an EC50 value of 92 7 nM in hCaR-HEK293 cells

ENCOMPASS_PREFERRED
4

Medchemexpress LLC 3-[(diaminomethylidene)amino]propanoic acid | 353-09-3 | MFCD00045939 | 99.9% | 131.14 g·mol⁻¹ | C4H9N3O2 | 100 MG
SDP

Ompenaclid (RGX-202) is an oral small-molecule inhibitor of the creatine transporter SLC6A8 used as a research compound and reference standard in preclinical studies. It inhibits creatine import, reduces intracellular phosphocreatine and ATP, and has demonstrated tumor apoptosis induction in model systems.

  • Inhibits SLC6A8 creatine transporter in vitro and in vivo.
  • Reduces intracellular phosphocreatine and ATP levels.
  • Induces tumor cell apoptosis in preclinical studies.
  • Available as high-purity solid or solution for research use.
  • Characterized by confirmed molecular formula and molecular weight.

ENCOMPASS_PREFERRED